TerminatedNCT00668265
Anxiety in Recovering Opiate Dependence
Medication studyAges 21–65United States
Understand this study
Who could participate?
Listed age limits: 21 years to 65 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJanuary 2008
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 14
- Sponsor
- Beth Israel Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT00668265
- Official title
Show the full official title
A Prospective, Sixteen-Week, Double-Blind, Placebo-Controlled, Trial of Seroquel in Combination With Treatment as Usual in Patients With GAD and Remitted Comorbid Opiate Dependence
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Questions about this study
Who is behind this study?
The study sponsor is Beth Israel Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Quetiapine.
Who can participate?
Listed age limits: 21 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
